2014
DOI: 10.1097/mib.0000000000000007
|View full text |Cite
|
Sign up to set email alerts
|

Venous Thromboembolism in Patients with Inflammatory Bowel Diseases

Abstract: Introduction Inflammatory bowel disease is a well known risk factor for venous thromboembolism (VTE). Existing guidelines for thromboprophylaxis in hospitalized patients do not extend to other clinical scenarios that may also be associated with VTE risk. Our aim was to estimate the fraction of VTE events in IBD patients that could be prevented. Methods A retrospective analysis assessed all IBD patients diagnosed with VTE at a single academic medical center from 2002–2012. Confirmed cases were analyzed for VT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
1
4

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(37 citation statements)
references
References 30 publications
1
31
1
4
Order By: Relevance
“…Patients with IBD are at increased risk of developing VTE upon hospital discharge compared with other patients [58]. The inflammatory cascade that increases risk of VTE likely also places patients with IBD at increased risk of heart failure [59] and atrial fibrillation [60] during periods of disease activity.…”
Section: Comorbiditiesmentioning
confidence: 99%
“…Patients with IBD are at increased risk of developing VTE upon hospital discharge compared with other patients [58]. The inflammatory cascade that increases risk of VTE likely also places patients with IBD at increased risk of heart failure [59] and atrial fibrillation [60] during periods of disease activity.…”
Section: Comorbiditiesmentioning
confidence: 99%
“…DVT occurs most often in the calf or thighs but can also originate in the proximal veins and is the primary cause of pulmonary thromboembolism [6]. Several diseases such as IBD and chronic kidney disease (CKD) have been implicated in the development of DVT, mainly by changes in coagulation factors and the production of pro-inflammatory mediators [7–9]. …”
Section: Introductionmentioning
confidence: 99%
“…At least four relevant studies were excluded due to unavailable ORs of VTE risk. 42,51,52 In the study of Scoville et al, 53 there were non-IBD VTE controls as comparators for VTE risk in IBD, which did not match the control group criteria in our meta-analysis. Additionally, we cannot rule out that we lost relevant articles by having imposed English language, as a filter, on the search.…”
Section: Discussionmentioning
confidence: 99%